NetworkNewsBreaks Archive - Page 419 of 1733

ThursdayApr 14, 2022 12:52 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Results from Pulmonary Hypertension Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released data from its HYPER-H21-3 human study. The company noted that data from its simulated pulmonary hypertension clinical study indicate positive safety and efficacy findings. Specifically, results show a tendency (p=0.1) during 15 minutes of simulated low levels of oxygen (hypoxia) for reduced pulmonary artery systolic pressure (“PASP”) with DehydraTECH-CBD treatment versus placebo. According to the announcement, PASP was significantly attenuated by about 5 mmHg or 41% overall (p=0.045) in male participants, which could indicate potential differences by sex in responsiveness to CBD treatment under hypoxic stress conditions. The…

ThursdayApr 14, 2022 11:11 am

NetworkNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Premier Product Launch Earns Finalist Status in Canadian Grand Prix New Product Awards

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, announced that Co-op Gold PURE Plant-Based Protein Twists were awarded finalist status in the 29th annual Canadian Grand Prix New Product Awards. The Protein Twists are sold under the white-label division of Federated Co-operatives Gold Brand and are the first product launch powered by Sapientia Technology LLC, EWGFF’s portfolio company. Eat Well Group acquired Sapientia last year as part of its strategic business model of investing in companies that are commercializing food-tech and R&D products within 12 to 18 months. The announcement called Sapientia’s ability to launch the…

ThursdayApr 14, 2022 9:42 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Featured in Latest Power Play Release

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), was spotlighted in an episode of the Power Play by the Market Herald. Cybin CEO Doug Drysdale talked with host Dave Jackson about the company’s recent positive results from its CYB004 pharmacokinetic study. The company announced that the study produced positive preclinical data demonstrating that when inhaled, Cybin’s deuterated dimethyltryptamine (“DMT”) molecule indicated advantages, such as a longer duration of action and improved bioavailability, over both IV DMT and inhaled DMT. Power Play interviews with company executives offer investors a quick snapshot of an array of…

WednesdayApr 13, 2022 1:18 pm

NetworkNewsBreaks – Hollywall Entertainment Inc. (HWAL) Empowering Small Communities to Pursue Concept Central to American Ideals

Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is focused on ensuring “digital equity” through access to the internet and its resources. “Hollywall president and CEO Darnell Sutton helped to pioneer the concept of ‘Fiber to the People’ as a way of empowering small communities, especially those in the South’s ‘Black Belt,’ to pursue the self-determination so central to American ideals. Hollywall’s HW Vision subsidiary is offering affordable high-speed internet access, telehealth, energy, web conferencing, domain and hosting, IoT, managed internet services, video broadcasting, and nationwide unlimited talk, text and data cellular phone plans to its customers,” a…

WednesdayApr 13, 2022 1:08 pm

NetworkNewsBreaks – American Cannabis Partners Buoyed by Positive Look-Ahead Market Evaluations

American Cannabis Partners (“ACP”) is expected to see increasing opportunities to market its products as the cannabis landscape continues to shift, with growing numbers of states allowing some form of the substance and federal legislation examining changes in legal status. A recent article, which contains excerpts from a Hemp Industry Daily (“HID”) piece that looked at cannabis marketing trends for this year, documents that while Google is cracking down on advertising cannabis, other platforms like Twitter, Reddit and Quora are opening up. The article reads: “‘Of all the social media platforms, we have our eyes set on streaming platforms like…

WednesdayApr 13, 2022 12:33 pm

NetworkNewsBreaks – SPYR Inc.’s (SPYR) Applied Magix Exploring Potential for Expansion into MVNO Market

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., are evaluating the potential for entering the mobile virtual network operators (“MVNO”) market by offering special mobile phone plans designed exclusively for iPhone users. Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar IoT smart-home and connected-car markets. The MVNO space has seen dramatic growth within the mobile phone space by offering more affordable plans. Because MVNOs don’t have their own wireless networks, they typically use another carrier’s platform to provide coverage. Applied Magix is exploring that possibility with various existing relationships. “There…

WednesdayApr 13, 2022 12:25 pm

NetworkNewsBreaks – Investor Summit Group, B2i Digital Inc. to Showcase Hand-Selected Presenting Companies at In-Person NYC Event

The Investor Summit Group, widely recognized for its reputation as the organizer of North America's largest and most reputable independent investor conferences, today announced that it will host its Q2 In-Person Investor Summit in Manhattan on May 3-4, 2022. The first major in-person small-cap and microcap conference to be held in New York City since the pandemic started, the event will bring together some of the continent's most exciting companies to interact with credible investors. For this special event, Investor Summit Group is partnering with B2i Digital to offer even more value to presenting companies. Each participating company will receive…

WednesdayApr 13, 2022 12:13 pm

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Health Canada 56 Exemption for Research on Psychedelic Compounds

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its subsidiary Delic Labs have received a Health Canada 56 Research Exemption. The exemption gives approval for the company to conduct research and perform tests on several compounds, including MDMA, LSD, mescaline and 2C-B. The exemption also allows the lab to obtain psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc. The company anticipates moving forward and developing innovative analytical methods for psychedelic research. According to the announcement, the lab has also submitted an application for a dealer’s license with…

WednesdayApr 13, 2022 11:51 am

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Completes SOC Certification Audit

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has completed the System and Organization Controls (“SOC”) 2 Type 2 certification audit. The audit, which started in November 2021, focused on controls relevant to the security trust services category. According to the announcement, SOC 2 Compliance is a recognized auditing standard developed by the American Institute of Certified Public Accountants (“AICPA”) that evaluates a service organization's systems and determines if specified controls meet relevant trust services categories. Considered the gold standard for establishing trust with customers, the audit also measures the effectiveness of those controls over a specified period…

WednesdayApr 13, 2022 11:35 am

NetworkNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Significant Advantages over IV and Inhaled DMT in Pharmacokinetic Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced positive preclinical data from a pharmacokinetic study evaluating its proprietary deuterated dimethyltryptamine (“DMT”) molecule, CYB004, delivered via inhalation. According to the announcement, inhaled CYB004 demonstrated significant advantages over both intravenous and inhaled DMT, including longer duration of action and improved bioavailability. The study also demonstrated that inhaled CYB004 showed a similar dose profile and onset of effect to IV DMT. “In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues. However, known side…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks